INS and Alzheimer disease: A longitudinal population study performed in South Korea showed as incidence, and the risk of PD increased gradually with the number of metabolic syndrome components, suggesting that neurodegenerative disease and metabolic abnormalities could share pathophysiological mechanisms (6); similarly, non-pharmacologic interventions can improve insulin sensitivity and ameliorate cognitive functions in AD individuals (7).